Ory Nacht

With over 22 years of experience, Mr. Nacht leads a diverse and extensive practice which includes handling complex cross-border mergers and acquisition; venture capital and private equity investments and other financings; initial public offerings and follow-on public offerings in the U.S. and Israel, proxy contests regarding Israeli public companies traded in the U.S., and business collaborations in the online gambling, social gaming, forex and contracts-for-difference (CFD) trading space.

• Advising Adama and Syngenta in an asset sale of $540 million.
• Advising Aristocrat Leisure in its acquisition of Plarium for an initial consideration of $500 million.
• Acting for Foamix Pharmaceuticals in a series of follow-on offerings on Nasdaq raising a total of over $200 million.
• Advising Honeywell in its acquisition of Nextnine for $40 million.
• Advising 888 in its acquisition of Betbright for £17 million.

• Capital markets: Equity
• Investment funds
• M&A
• Private equity
• Private equity funds

• Construction and materials
• Financial services
• Gaming
• Pharma and life sciences
• Tech and telecoms

• Israel

• L.L.B., Tel Aviv University, 1996